Quantification of antigen specific CD8+ T cells using an ELISPOT assay.
about
A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responsesBoosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccineAntigens in tea-beverage prime human Vgamma 2Vdelta 2 T cells in vitro and in vivo for memory and nonmemory antibacterial cytokine responsesMHC class I multimersMarked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray.Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletionsCD8+ T-cells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental Trypanosoma cruzi-elicited cardiomyopathyEnhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer.Discovery of CD8+ T cell epitopes in Chlamydia trachomatis infection through use of caged class I MHC tetramersImmunization Strategies against Piscirickettsia salmonis Infections: Review of Vaccination Approaches and Modalities and Their Associated Immune Response ProfilesPentoxifylline reverses chronic experimental Chagasic cardiomyopathy in association with repositioning of abnormal CD8+ T-cell responseVaccine efficacy against malaria by the combination of porcine parvovirus-like particles and vaccinia virus vectors expressing CS of PlasmodiumImmunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infectionAlloantibody production is regulated by CD4+ T cells' alloreactive pathway, rather than precursor frequency or Th1/Th2 differentiation.Modulation of CD4(+) T cell-dependent specific cytotoxic CD8(+) T cells differentiation and proliferation by the timing of increase in the pathogen load.A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon.Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimenRecombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice.Heat-shocked tumor cell lysate-pulsed dendritic cells induce effective anti-tumor immune response in vivo.The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells.Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway.Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungsVaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunityDelivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity.A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings.Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide.Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigenEvaluation of the modified ELISPOT assay for gamma interferon production in cancer patients receiving antitumor vaccines.Noncompetitive expansion of cytotoxic T lymphocytes specific for different antigens during bacterial infection.Lack of CD4(+) T cells does not affect induction of CD8(+) T-cell immunity against Encephalitozoon cuniculi infection.Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains.Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85BA Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice.Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infectionNaturally exposed populations differ in their T1 and T2 responses to the circumsporozoite protein of Plasmodium falciparum.Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacyMacrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimuriumQuantitative and qualitative features of heterologous virus-vector-induced antigen-specific CD8+ T cells against Trypanosoma cruzi infection.Protective immunity to Listeria monocytogenes infection mediated by recombinant Listeria innocua harboring the VGC locus.Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice.
P2860
Q21135240-79E99483-DAB7-4E9C-8B50-847999E1E600Q24650662-82908A8E-3916-417C-85D8-4EC6C7B250A2Q24675038-AA54B082-A14A-4003-9FB3-A60F186FFB77Q24805668-A7F524AC-AEDA-479B-A949-E0BDB16AE25BQ24815128-3FD9BBEB-D32D-4744-AF6A-FBB94FC68E67Q27320923-F6730723-E157-46A8-83A6-012F3A054863Q27346448-DE752CA7-8469-43C2-A4B3-4C66CC891B2BQ27469698-5182475D-89D2-4ECE-BB01-BD3F9FCAF6E4Q27649766-B965629E-6C65-49D8-AEFB-AE21FB31D67CQ28067442-692BCD61-712E-46FA-A8A8-AC838C600EF2Q28544692-FAFDF001-1EA3-4F6E-9576-FC4FCAE545B6Q28730541-1635F321-0CC0-4331-AB31-EA0E109306C4Q30452989-E750AF4C-7BB8-414C-9541-6C008CEBCC6AQ33205084-0BC36EA1-A171-4F58-B667-46D577955C70Q33282864-23E4F71D-0417-4B35-A34B-60403414B841Q33603919-9BF383FC-D8D0-4021-A6AF-5AEDB7129819Q33649842-0679FEA9-BD78-49FB-A3EB-E545DC3EB3F5Q33783688-D4006AF9-C43A-42C9-9D4A-F8442D91FE2EQ33788255-5D1C905D-4A64-4C45-8A26-35A00D83C235Q33797749-C8B91835-CD49-494A-A5D1-CE9AB6EF6FF8Q33806715-C4A57831-5D2F-4B59-9036-EC112E62DEC7Q33812288-26A27774-375F-4E40-9EB1-18F364DEEB2CQ33846454-47833E0D-7233-45FC-83A9-1469D6FD9F8EQ33852549-921DBDB3-10A1-488C-BF96-EFA0322EC1E9Q33908062-43574039-90EB-4855-A463-041B37675012Q33909760-06BE4AF8-2CBE-4951-B5F2-1B3678E3C7A9Q33944652-D6ECD940-95A4-411F-BD2F-C3764E23235FQ33998189-F2602F45-A62B-4CF6-98BF-92677EF9BE88Q34000642-CB433388-1E61-4A50-A5F1-9E0539DD53B4Q34004978-42E23EFC-361A-40A5-BFC2-522B5032FFC0Q34006127-897D664C-E4D7-4E6A-B24F-071684CEF34DQ34033825-1F919C28-58F3-4031-8872-FF5BC8CAA06AQ34098868-B5192F38-481D-446F-A1CB-12E4B2337EA4Q34111806-2AB68991-9BB1-46E7-BAAB-CDABD3EAD3BBQ34119044-4F4A6D8F-4AB5-471E-891B-0C358E9F123FQ34130841-9477D705-5F33-4BCE-B5B6-E28910012E6DQ34160505-CC4A2902-1365-4976-9F7C-6F9319282F80Q34188729-94D26F58-2D68-43CE-AFFB-7C4BBA0857A5Q34247324-B70FC2BC-AF35-48C9-AAE3-13D7DCAECA47Q34301004-1787D832-1448-48F4-BB25-E320DD171039
P2860
Quantification of antigen specific CD8+ T cells using an ELISPOT assay.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Quantification of antigen specific CD8+ T cells using an ELISPOT assay.
@en
Quantification of antigen specific CD8+ T cells using an ELISPOT assay.
@nl
type
label
Quantification of antigen specific CD8+ T cells using an ELISPOT assay.
@en
Quantification of antigen specific CD8+ T cells using an ELISPOT assay.
@nl
prefLabel
Quantification of antigen specific CD8+ T cells using an ELISPOT assay.
@en
Quantification of antigen specific CD8+ T cells using an ELISPOT assay.
@nl
P2093
P1476
Quantification of antigen specific CD8+ T cells using an ELISPOT assay.
@en
P2093
Miyahira Y
Rodrigues MM
Rodriguez D
Rodriguez JR
P356
10.1016/0022-1759(94)00327-S
P577
1995-04-01T00:00:00Z